Babies under six months can develop type 1 diabetes, and the condition may begin to take root before they are born, according to scientists. It was previously thought infants who are less than six months old could only develop neonatal diabetes – which is caused by a genetic mutation that affects the pancreas cells which… Read More »
Coronavirus cases in England have “increased rapidly”, data shows, as ministers grapple with what to do next. Estimates suggest between one-in-170 and one-in-240 people you meet in the street has the virus. Both current cases, and the speed at which they are increasing, are much higher in the north of England than the national average.… Read More »
FDA Approves Alkindi Sprinkle (hydrocortisone oral granules) for Pediatric Adrenocortical Insufficiency DEER PARK, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Alkindi Sprinkle (hydrocortisone)… Read More »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »